| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.032 | 0.9 |